Advertisement

Experientia

, Volume 27, Issue 1, pp 112–113 | Cite as

Dosage de la noradrénaline, de la dopamine et de l'acide dihydroxyphénylacétique dans certains noyaux du cerveau de Rat

  • J. Gérardy
  • N. Quinaux
  • A. Dresse
Specialia Pro Experimentis

Summary

After thin-layer chromatography separation, we have assayed quantitatively noradrenaline, dopamine and its deaminated metabolite 3–4 dihydroxyphenylacetic acid by the ethylenediamine method. In the hypothalamus and the caudate nucleus, the values obtained for the amines and phenolic acid estimation are equivalent or higher than those found by other authors. The presence of ascorbic acid has been shown in the caudate nucleus.

References

  1. 2.
    D. Aurès, R. Fleming etR. Håkanson, J. Chromat.33, 480 (1968).CrossRefGoogle Scholar
  2. 3.
    J. Gérardy, N. Quinaux, T. Maeda etA. Dresse, Archs int. Pharmacodyn. Thér.177, 492 (1969).Google Scholar
  3. 4.
    S. Udenfriend,Fluorescence Assay (Academic Press, New York 1962), p. 154.Google Scholar
  4. 5.
    A. Vahidi etD. V. Siva Sankar, J. Chromat.43, 135 (1969).CrossRefGoogle Scholar
  5. 6.
    J. B. Parratt etG. B. West, J. Physiol., Lond.137, 169 (1957).CrossRefPubMedPubMedCentralGoogle Scholar
  6. 7.
    H. F. Schneider etC. N. Gillis, Biochem. Pharmac.14, 623 (1965).CrossRefGoogle Scholar
  7. 8.
    H. Weil-Malherbe etA. D. Bone, Biochem. J.51, 311 (1952).CrossRefPubMedPubMedCentralGoogle Scholar
  8. 9.
    G. F. Murphy, D. Robinson etD. F. Sharman, Br. J. Pharmac.36, 107 (1969).CrossRefGoogle Scholar
  9. 10.
    J. Kägi, M. Burger etK. Giger, Arch. exp. Path. Pharmak.230, 470 (1957).Google Scholar
  10. 11.
    N. E. Anden, B. E. Roos etB. Werdinius, Life Sci.3, 149 (1964).CrossRefGoogle Scholar
  11. 12.
    N. E. Anden, B. E. Roos etB. Werdinius, Life Sci.2, 319 (1963).CrossRefGoogle Scholar
  12. 13.
    A. Carlsson etN. A. Hillarp, Acta physiol. scand.55, 95 (1962).CrossRefPubMedGoogle Scholar
  13. 14.
    D. F. Sharman, Br. J. Pharmac.28, 153 (1966).Google Scholar
  14. 15.
    H. Green etR. W. Erickson, J. Pharmac. exp. Ther.129, 237 (1960).Google Scholar
  15. 16.
    R. Laverty etD. F. Sharman, Br. J. Pharmac.24, 759 (1965).Google Scholar
  16. 17.
    W. P. de Potter, R. F. Vochten etA. F. de Schaepdryver, Experientia21, 482 (1965).CrossRefPubMedGoogle Scholar
  17. 18.
    R. Kuntzman, P. A. Shore, D. Bogdanski etB. B. Brodie, J. Neurochem.6, 226 (1961).CrossRefPubMedGoogle Scholar
  18. 19.
    H. Nybäck etG. Sedvall, Eur. J. Pharmac.5, 245 (1969).CrossRefGoogle Scholar
  19. 20.
    S. Kaufman, Pharmac. Rev.18, 61 (1966).Google Scholar
  20. 21.
    S. Udenfriend etC. R. Creveling, J. Neurochem.4, 350 (1959).CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1971

Authors and Affiliations

  • J. Gérardy
    • 1
  • N. Quinaux
    • 1
  • A. Dresse
    • 1
  1. 1.Institut de Thérapeutique expérimentaleUniversité de LiègeLiègeBelgium

Personalised recommendations